Skip to main content
. 2020 Dec 29;180(1):136–147. doi: 10.1093/toxsci/kfaa184

Figure 3.

Figure 3.

DNCB modified HLA peptide peptide-spectrum matches: A, B, C, D, Peptide-spectrum matches for RFC(+DNP)PFAERTR DNCB modified HLA-A31 peptide from glutathione-S-transferase omega-1 (Uniprot: P78417), AETEC(+DNP)RYAL DNCB modified HLA-B40 peptide from Keratin, type I cytoskeletal 13 (Uniprot: P13646), GLLDPQC(+DNP)RL DNCB modified HLA-A2 peptide from Ribonuclease inhibitor (Uniprot: P13489) and KLLEGEEC(+DNP)RL DNCB modified HLA-A2 peptide from Keratin, type II cytoskeletal 5 (Uniprot: P13647). E, F, G, H, Peptide-spectrum matches for RFC(+DNP)PFAERTR, AETEC(+DNP)RYAL, GLLDPQC(+DNP)RL, KLLEGEEC(+DNP)RL synthetic peptides.